Cidofovir diphosphate inhibits molluscum contagiosum virus DNA polymerase activity

Journal of Investigative Dermatology

Volumn 128, Issue 5, 2008, Pages 1327-1329

  Watanabe, Takahiro ^a,b   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMMONIUM SULFATE; ANTIVIRUS AGENT; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; MESSENGER RNA; NUCLEOSIDE ANALOG; PYROPHOSPHATE; RECOMBINANT PROTEIN; SMALLPOX VACCINE; THYMIDINE KINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MOLECULAR CLONING; MOLLUSCIPOXVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; TISSUE CULTURE; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 42149137428     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701161     Document Type: Letter

References (15)

1. Baker RO, Bray M, Huggins JW (2003) Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res 57:13-23
2. Davies EG, Thrasher A, Lacey K, Harper J (1999) Topical cidofovir for severe molluscum contagiosum. Lancet 353:2042
3. Dorsky DI, Crumpacker CS (1988) Expression of herpes simplex virus type 1 DNA polymerase gene by in vitro translation and effects of gene deletions on activity. J Virol 62:3224-32
4. Geerinck K, Lukito G, Snoeck R, De Vos R, De Clercq E, Vanrenterghem Y et al. (2001) A case of human orf in an immunocompromised patient treated successfully with cidofovir cream. J Med Virol 64:543-9
5. Gubser C, Hue S, Kellam P, Smith GL (2004) Poxvirus genomes: a phylogenetic analysis. J Gen Virol 85:105-17
6. Haffey ML, Stevens JT, Terry BJ, Dorsky DI, Crumpacker CS, Wietstock SM et al. (1988) Expression of herpes simplex virus type 1 DNA polymerase in Saccharomyces cerevisiae and detection of virus-specific enzyme activity in cell-free lysates. J Virol 62:4493-8
7. Hitchcock MJM, Jaffe HS, Martin JC, Stagg RJ (1996) Cidofovir, a new agent with potent anti-herpesvirus activity. Antimicrob Agents Chemother 7:115-27
8. Loregian A, Case A, Cancellotti E, Valente C, Marsden HS, Palu G (2006) Cloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit. J Virol 80:6247-58
9. McDonald WF, Traktman P (1994) Overexpression and purification of the vaccinia virus DNA polymerase. Protein Expr Purif 5:409-21
10. Meadows KP, Tyring SK, Pavia AT, Rallis TM (1997) Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol 134:1169-70
11. Neyts J, De Clercq E (2003) Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives. Antiviral Res 57:25-33
12. Safrin S, Cherrington J, Jaffe HS (1997) Clinical uses of cidofovir. Rev Med Virol 7:145-56
13. Stittelaar KJ, Neyts J, Naesens L, van Amerongen G, van Lavieren RF, Holy A et al. (2006) Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 439:745-8
14. Toro JR, Wood LV, Patel NK, Turner ML (2000) Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch Dermatol 136:983-5
15. Zabawski EJ Jr, Cockerell CJ (1999) Topical cidofovir for molluscum contagiosum in children. Pediatr Dermatol 16:414-5